Real-time enrollment status for this hr+ breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:45 AM UTC
| NCT Number | NCT07029399 |
| Recruiting Status | Recruiting |
| Condition | HR+ Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 361 participants |
| Active Locations | 18 sites in the US |
| Sponsor | NiKang Therapeutics, Inc. |
| Last Updated on CT.gov | June 26, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT07029399 is currently recruiting participants. This clinical trial study for hr+ breast cancer is actively seeking new participants at 18 locations across the United States. The study is sponsored by NiKang Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07029399 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07029399 was last updated 2 weeks ago (June 26, 2026). HelloStudys verifies this status automatically.